rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
1978-1-27
|
pubmed:abstractText |
Muscarinic receptors have been characterized in smooth muscle and brain by the binding of reversible (e.g. atropine, quinuclidinylbenzylate) or irreversible (benzilylcholine or propylbenzilylcholine mustards) ligands. There is a close correlation between affinity constants derived from binding experiments and the affinities of muscarinic ligands for these sites obtained in pharmacological experiments on smooth muscle. Whereas atropine shows a single high affinity binding component (in subcellular preparations) several other ligands (QNB, ACh, oxotremorine) show multiple affinity binding. This indicated the existence of several types of binding sides which show selectivity toward certain cholinergic effectors. Most detergents inhibit the binding of ligands to the receptor site and therefore cannot be used to solubilize the receptor protein from the membrane. Treatment of brain subcellular membrane preparations with high salt concentrations (2M NaI) solubilize proteins which possess the muscarinic ligand binding properties observed in the membrane preparation. The affinities for muscarinic antagonists however are decreased, which suggests that a conformational change occurs in the protein upon solubilization.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Acetylcholine,
http://linkedlifedata.com/resource/pubmed/chemical/Alkylating Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Atropine,
http://linkedlifedata.com/resource/pubmed/chemical/Carbachol,
http://linkedlifedata.com/resource/pubmed/chemical/Choline,
http://linkedlifedata.com/resource/pubmed/chemical/Dexetimide,
http://linkedlifedata.com/resource/pubmed/chemical/Ligands,
http://linkedlifedata.com/resource/pubmed/chemical/Quinuclidines,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Cholinergic,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Muscarinic
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0300-0893
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
26
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
250-9
|
pubmed:dateRevised |
2003-11-14
|
pubmed:meshHeading |
pubmed-meshheading:579159-Acetylcholine,
pubmed-meshheading:579159-Alkylating Agents,
pubmed-meshheading:579159-Animals,
pubmed-meshheading:579159-Atropine,
pubmed-meshheading:579159-Binding, Competitive,
pubmed-meshheading:579159-Brain,
pubmed-meshheading:579159-Carbachol,
pubmed-meshheading:579159-Cattle,
pubmed-meshheading:579159-Choline,
pubmed-meshheading:579159-Dexetimide,
pubmed-meshheading:579159-Kinetics,
pubmed-meshheading:579159-Ligands,
pubmed-meshheading:579159-Muscle, Smooth,
pubmed-meshheading:579159-Muscle Contraction,
pubmed-meshheading:579159-Quinuclidines,
pubmed-meshheading:579159-Rats,
pubmed-meshheading:579159-Receptors, Cholinergic,
pubmed-meshheading:579159-Receptors, Muscarinic,
pubmed-meshheading:579159-Solubility,
pubmed-meshheading:579159-Subcellular Fractions
|
pubmed:year |
1977
|
pubmed:articleTitle |
Biochemical studies on muscarinic receptors.
|
pubmed:publicationType |
Journal Article
|